"10.1371_journal.pone.0057263","plos one","2013-02-25T00:00:00Z","Edward Coulstock; Jane Sosabowski; Milan Ovečka; Rob Prince; Laura Goodall; Clare Mudd; Armin Sepp; Marie Davies; Julie Foster; Jerome Burnet; Gráinne Dunlevy; Adam Walker","Innovation Biopharm Discovery Unit, Biopharm R&D, GlaxoSmithKline, Cambridge, United Kingdom; Centre for Molecular Oncology, Barts Cancer Institute, Queen Mary University of London, London, United Kingdom","Conceived and designed the experiments: EC JS MO LG AS RP MD AW. Performed the experiments: EC JS MO RP LG CM AS JF JB GD. Analyzed the data: EC JS MO LG AS RP MD AW. Contributed reagents/materials/analysis tools: EC JS MO RP LG AS. Wrote the paper: EC AW.","The authors have read the journal‚s policy and have the following conflicts: All authors (except JS, JF, and JB) were employees of GlaxoSmithKline at the time this work was carried out. JS, JF, and JB are researchers at Queen Mary University of London whose work on this project was funded by GlaxoSmithKline. All relevant patents have been declared, and there are no products in development or marketed products to declare. This does not alter the authors‚ adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.","2013","02","Edward Coulstock","EC",12,TRUE,8,10,8,2,TRUE,TRUE,FALSE,0,NA,FALSE
